Adelaide Research & Scholarship: Search

Search

Results 11-20 of 26 (Search time: 0.001 seconds).

Item hits:

Preview	Issue Date	Title	Author(s)
	2000	Mucopolysaccharidosis type IIIB: characterisation and expression of wild-type and mutant recombinant a-N-acetylglocosaminidase and relationship with Sanfilippo phenotype in an attenuated patient	Yogalingam, G.; Weber, B.; Meehan, J.; Rogers, J.; Hopwood, J.
	2006	Galsulfase	Hopwood, J.; Bate, G.; Kirkpatrick, P.
	2005	Replacing acid ∝-glucosidase in Pompe disease: recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibers	Raben, N.; Fukuda, T.; Gilbert, A.; de Jong, D.; Thurberg, B.; Mattaliano, R.; Meikle, P.; Hopwood, J.; Nagashima, K.; Nagaraju, K.; Plotz, P.
	2006	Intra-articular enzyme administration for joint disease in feline mucopolysaccharidosis VI: Enzyme dose and interval	Auclair, D.; Hein, L.; Hopwood, J.; Byers, S.
	2004	Monitoring dose response of enzyme replacement therapy in feline mucopolysaccharidosis type VI by tandem mass spectrometry	Crawley, A.; Ramsay, S.; Byers, S.; Hopwood, J.; Meikle, P.
	2004	Enzyme-replacement therapy from birth delays the development of behavior and learning problems in mucopolysaccharidosis type IIIA mice	Gliddon, B.; Hopwood, J.
	2000	Enzyme replacement therapy in a feline model of MPS VI: Modification of enzyme structure and dose frequency	Byers, S.; Crawley, A.; Brumfield, L.; Nuttall, J.; Hopwood, J.
	2006	Detection of mucopolysaccharidosis type II by measurement of iduronate-2-sulfatase in dried blood spots and plasma samples	Dean, C.; Bockmann, M.; Hopwood, J.; Brooks, D.; Meikle, P.
	2009	Delivery of recombinant proteins via the cerebrospinal fluid as a therapy option for neurodegenerative lysosomal storage diseases	Hemsley, K.; Hopwood, J.
	2001	Expression and characterization of human recombinant and a-N-actylglucosaminidase	Weber, B.; Hopwood, J.; Yogalingam, G.